Literature DB >> 10567212

Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.

J R Davies1, N Svitacheva, L Lannefors, R Kornfält, I Carlstedt.   

Abstract

To investigate the genetic identities of the mucins secreted in cystic fibrosis (CF) airways, sputum was collected from five individuals. Samples were separated into gel and sol phases by high-speed centrifugation and the gel phase was extracted in 6 M guanidinium chloride. The 'insoluble' residue remaining after extraction of the gel phase was brought into solution by reduction/alkylation. Density-gradient centrifugation in CsCl revealed polydisperse distributions of sialic acid-containing mucins in the gel phase, insoluble residue and sol phase fractions and the degree of variation between the different individuals was low. Antibodies recognizing MUC5AC and MUC5B identified these mucins in each of the fractions. MUC2, however, was present only as a component of the insoluble residue from the gel which accounted for less than 4% by mass of the total mucins. MUC5B and MUC5AC from the gel phase were large oligomeric species composed of disulphide-bond linked subunits and MUC5B was present as two populations with different charge densities which are likely to correspond to MUC5B 'glycoforms'. The sol phase contained, in addition to MUC5AC and MUC5B, mainly smaller mucins which did not react with the antisera and which were probably degraded. MUC5AC appeared to be enriched in the sol, suggesting that this mucin may be more susceptible to proteolytic degradation than MUC5B. The mucins present in sputum remained broadly similar during acute exacerbation and following antibiotic treatment, although the relative amount of an acidic MUC5B glycoform was decreased during infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567212      PMCID: PMC1220647     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Size heterogeneity of human cervical mucus glycoproteins. Studies performed with rate-zonal centrifugation and laser light-scattering.

Authors:  J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

2.  Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.

Authors:  D J Thornton; J K Sheehan; H Lindgren; I Carlstedt
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  Heterogeneity of mucus glycoproteins from cystic fibrotic sputum. Are there different families of mucins?

Authors:  D J Thornton; J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

4.  Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis.

Authors:  P W Cheng; T F Boat; K Cranfill; J R Yankaskas; R C Boucher
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Studies on the "insoluble" glycoprotein complex from human colon. Identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage.

Authors:  A Herrmann; J R Davies; G Lindell; S Mårtensson; N H Packer; D M Swallow; I Carlstedt
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

6.  The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue.

Authors:  C Gerard; R L Eddy; T B Shows
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals.

Authors:  M C Rose; C F Brown; J Z Jacoby; W S Lynn; B Kaufman
Journal:  Pediatr Res       Date:  1987-11       Impact factor: 3.756

8.  Human bronchus and intestine express the same mucin gene.

Authors:  B H Jany; M W Gallup; P S Yan; J R Gum; Y S Kim; C B Basbaum
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Mucus glycoproteins from 'normal' human tracheobronchial secretion.

Authors:  D J Thornton; J R Davies; M Kraayenbrink; P S Richardson; J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

10.  Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria.

Authors:  A Dohrman; S Miyata; M Gallup; J D Li; C Chapelin; A Coste; E Escudier; J Nadel; C Basbaum
Journal:  Biochim Biophys Acta       Date:  1998-04-28
View more
  39 in total

1.  Differential regulation of MUC5AC/Muc5ac and hCLCA-1/mGob-5 expression in airway epithelium.

Authors:  Philip Thai; Yin Chen; Gregory Dolganov; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-08       Impact factor: 6.914

2.  Functional analysis of human MUC7 mucin gene 5'-flanking region in lung epithelial cells.

Authors:  Shimin Li; Libuse A Bobek
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-15       Impact factor: 6.914

Review 3.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 4.  Regulation of airway mucin gene expression.

Authors:  Philip Thai; Artem Loukoianov; Shinichiro Wachi; Reen Wu
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

5.  Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.

Authors:  Sara Kirkham; John K Sheehan; David Knight; Paul S Richardson; David J Thornton
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 6.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

7.  Vanadium pentoxide (V(2)O(5)) induced mucin production by airway epithelium.

Authors:  Dongfang Yu; Dianne M Walters; Lingxiang Zhu; Pak-Kei Lee; Yin Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-29       Impact factor: 5.464

8.  Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells.

Authors:  Yoshifumi Imamura; Katsunori Yanagihara; Yohei Mizuta; Masafumi Seki; Hideaki Ohno; Yasuhito Higashiyama; Yoshitsugu Miyazaki; Kazuhiro Tsukamoto; Yoichi Hirakata; Kazunori Tomono; Jun-ichi Kadota; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Heterogeneity and persistence length in human ocular mucins.

Authors:  A N Round; M Berry; T J McMaster; S Stoll; D Gowers; A P Corfield; M J Miles
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

10.  Human preocular mucins reflect changes in surface physiology.

Authors:  M Berry; R B Ellingham; A P Corfield
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.